Work

Idelalisib Given Front-Line for the Treatment of Chronic Lymphocytic Leukemia Results in Frequent and Severe Immune-Mediated Toxicities

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.497.497

Authors: Benjamin L Lampson, Tiago Matos, Haesook T. Kim, Siddha Kasar, Elizabeth A. Morgan, Masahiro Hirakawa, Joshua Fein, Stacey M. Fernandes, Jerome Ritz, Jennifer R. Brown

Institutions: Dana-Farber Cancer Institute, Harvard University, Brigham and Women's Hospital

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2556925907

FWCI: 4.403

Cites:

Cited by: 29

Related to: 10